Genmab | Capital Social Ordinario



Ordinary Share Capital Cambio Fecha
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Almirall EUR 214.79M 189.17M 2025-06
Amarin USD 308.15M 2.85M 2025-03
Amgen USD 538M 33.04B 2025-06
argenx SE 61.17M 405.3K 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Bayer EUR 982.42M 1.53B 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Demant DKK 205.72M 161.72M 2025-06
Exelixis USD 270.13M 269.86M 2025-07
Fresenius Medical Care EUR 293.41M 0 2025-06
Galapagos EUR 65.9M 228.04M 2025-06
Genmab DKK 10M 56M 2025-03
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
GN Store Nord DKK 604M 0 2025-03
GRIFOLS EUR 680.41M 560.8M 2025-06
Hikma Pharmaceutical USD 40M 0 2024-12
Insmed USD 211.11M 209.29M 2025-06
Lonza CHF 72M 0 2024-12
Merck EUR 434.78M 130.22M 2025-06
Novartis USD 793M 0 2024-12
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
UCB EUR 584M 0 2024-12


Genmab Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.